Regeneron Pharmaceuticals
REGN
#299
Rank
โ‚น7.772 T
Marketcap
โ‚น75,496
Share price
-1.00%
Change (1 day)
51.06%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): โ‚น458.22 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.91 Billion. In 2025 the company made an earning of โ‚น501.11 Billion, an increase over its 2024 earnings that were of โ‚น457.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น458.22 B-8.56%
2025 โ‚น501.11 B9.43%
2024 โ‚น457.92 B13.83%
2023 โ‚น402.30 B-13.57%
2022 โ‚น465.48 B-47.9%
2021 โ‚น893.43 B144.75%
2020 โ‚น365.04 B56.86%
2019 โ‚น232.71 B-4.87%
2018 โ‚น244.63 B22.86%
2017 โ‚น199.12 B56.3%
2016 โ‚น127.39 B8.55%
2015 โ‚น117.36 B54.53%
2014 โ‚น75.95 B11.14%
2013 โ‚น68.34 B72.13%
2012 โ‚น39.70 B-285.93%
2011 -โ‚น21.36 Billion121.73%
2010 -โ‚น9.64 Billion37.18%
2009 -โ‚น7.03 Billion-14.6%
2008 -โ‚น8.23 Billion-25.02%
2007 -โ‚น10.97 Billion6.32%
2006 -โ‚น10.32 Billion-186.52%
2005 โ‚น11.91 B2103.7%
2004 โ‚น0.54 B-105.66%
2003 -โ‚น9.56 Billion-18.18%
2002 -โ‚น11.69 Billion42.33%
2001 -โ‚น8.21 Billion129.35%
2000 -โ‚น3.58 Billion51.87%
1999 -โ‚น2.36 Billion92.19%
1998 -โ‚น1.23 Billion66.23%
1997 -โ‚น0.74 Billion-55.49%
1996 -โ‚น1.66 Billion103.53%
1995 -โ‚น0.82 Billion-70.89%
1994 -โ‚น2.8 Billion-26.08%
1993 -โ‚น3.79 Billion114.67%
1992 -โ‚น1.77 Billion196.77%
1991 -โ‚น0.6 Billion87.88%
1990 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.488 T 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.512 T 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น870.55 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น733.69 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น155.48 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น83.31 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA